Communication between the ATPase and cleavage/religation domains of human topoisomerase IIα

被引:38
作者
Bjergbaek, L
Kingma, P
Nielsen, IS
Wang, Y
Westergaard, O
Osheroff, N
Andersen, AH
机构
[1] Aarhus Univ, Dept Biol Mol & Struct, DK-8000 Aarhus C, Denmark
[2] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
关键词
D O I
10.1074/jbc.275.17.13041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The DNA strand passage activity of eukaryotic topoisomerase II relies on a cascade of conformational changes triggered by ATP binding to the N-terminal domain of the enzyme. To investigate the interdomain communication between the ATPase and cleavage/religation domains of human topoisomerase II alpha, we characterized a mutant enzyme that contains a deletion at the interface between the two domains, covering amino acids 350-407. The ATPase domain retained full activity with a rate of ATP hydrolysis that was severalfold higher than normal, but the ATPase activity was unaffected by DNA. The cleavage and religation activities of the enzyme were comparable with those of the wild-type enzyme both in the absence and presence of cancer chemotherapeutic agents. However, neither ATP nor a nonhydrolyzable ATP analog stimulated cleavage complex formation, Although both conserved domains retained full activity, the mutant enzyme was unable to coordinate these activities into strand passage. Our findings suggest that the normal conformational transitions occurring in the enzyme upon ATP binding are hampered or lacking in the mutant enzyme. Consistent with this hypothesis, the enzyme displayed an abnormal clamp closing activity. In summary, the region covering amino acids 350-407 in human topoisomerase II alpha seems to be essential for correct interdomain communication and probably is involved in signaling ATP binding to the rest of the enzyme.
引用
收藏
页码:13041 / 13048
页数:8
相关论文
共 43 条
[1]   THE 43-KILODALTON N-TERMINAL FRAGMENT OF THE DNA GYRASE-B PROTEIN HYDROLYZES ATP AND BINDS COUMARIN DRUGS [J].
ALI, JA ;
JACKSON, AP ;
HOWELLS, AJ ;
MAXWELL, A .
BIOCHEMISTRY, 1993, 32 (10) :2717-2724
[2]  
ANDERSEN AH, 1991, J BIOL CHEM, V266, P9203
[3]   NOVEL HELA TOPOISOMERASE-II IS THE II-BETA ISOFORM - COMPLETE CODING SEQUENCE AND HOMOLOGY WITH OTHER TYPE-II TOPOISOMERASES [J].
AUSTIN, CA ;
SNG, JH ;
PATEL, S ;
FISHER, LM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1172 (03) :283-291
[4]   Topoisomerase II drives DNA transport by hydrolyzing one ATP [J].
Baird, CL ;
Harkins, TT ;
Morris, SK ;
Lindsley, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :13685-13690
[5]   Structure and mechanism of DNA topoisomerase II [J].
Berger, JM ;
Gamblin, SJ ;
Harrison, SC ;
Wang, JC .
NATURE, 1996, 379 (6562) :225-232
[6]   Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms [J].
Biersack, H ;
Jensen, S ;
Gromova, I ;
Nielsen, IS ;
Westergaard, O ;
Andersen, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8288-8293
[7]   Using a biochemical approach to identify the primary dimerization regions in human DNA topoisomerase IIα [J].
Bjergbæk, L ;
Jensen, S ;
Westergaard, O ;
Andersen, AH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26529-26536
[8]   Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme [J].
Burden, DA ;
Osheroff, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :139-154
[9]  
Caron P R, 1994, Adv Pharmacol, V29B, P271
[10]   Analysis of a core domain in Drosophila DNA topoisomerase II -: Targeting of an antitumor agent ICRF-159 [J].
Chang, S ;
Hu, T ;
Hsieh, TS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (31) :19822-19828